Presymptomatic and symptomatic ALS SOD1(G93A) mice differ in adenosine A1 and A2A receptor-mediated tonic modulation of neuromuscular transmission.
about
New perspectives on amyotrophic lateral sclerosis: the role of glial cells at the neuromuscular junction.The neuroprotective effects of caffeine in neurodegenerative diseases.Purinergic Signalling: Therapeutic Developments.Downregulated Glia Interplay and Increased miRNA-155 as Promising Markers to Track ALS at an Early Stage.Amyotrophic Lateral Sclerosis (ALS) and Adenosine Receptors.Purinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy.
P2860
Presymptomatic and symptomatic ALS SOD1(G93A) mice differ in adenosine A1 and A2A receptor-mediated tonic modulation of neuromuscular transmission.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Presymptomatic and symptomatic ...... of neuromuscular transmission.
@ast
Presymptomatic and symptomatic ...... of neuromuscular transmission.
@en
type
label
Presymptomatic and symptomatic ...... of neuromuscular transmission.
@ast
Presymptomatic and symptomatic ...... of neuromuscular transmission.
@en
prefLabel
Presymptomatic and symptomatic ...... of neuromuscular transmission.
@ast
Presymptomatic and symptomatic ...... of neuromuscular transmission.
@en
P2860
P1476
Presymptomatic and symptomatic ...... of neuromuscular transmission.
@en
P2093
Filipe Nascimento
Joaquim A Ribeiro
P2860
P2888
P304
P356
10.1007/S11302-015-9465-4
P577
2015-09-03T00:00:00Z